HBM4EU ICI EQUAS report BFR in serum round 2



Last Updated: 17-10-2019 10:55


Within the frame of the HBM4EU project, an External Quality Assurance Schemes (EQUAS) was organised on the determination of 10 BFR biomarkers in serum. This was the 2nd ICI/EQUAS round for this substance group within the HBM4EU program.
In total 31 candidate laboratories were invited for this 2nd ICI/EQUAS and 14 laboratories submitted results.
In November 2018, each participant received one tube of burdened control materials of serum (level 1, low = L1), one tube of burdened control materials of serum (level 2, high = L2) and one tube for “blank” serum (non spiked). The biomarker concentrations were mostly in the range of 0.15-4.1 ng/mL and 0.6-14 ng/mL for level 1 and level 2, respectively. The concentrations were chosen according to the review of relevant data on the occurrence of BFRs in serum of European population
published mostly during last five years.
A homogeneity assessment showed that both materials were sufficiently homogeneous for the EQUAS testing. The stability test demonstrated no significant loss of the biomarkers during the course.
The proficiency of the laboratories was assessed through Z-scores calculated using the expertassigned values, which were based on results obtained from the analysis of the control material by at least three expert laboratories selected by HBM4EU QAU. The expert assigned values were calculated by averaging the values obtained by the expert labs for BDE-47, BDE-153, BDE-209, DP-syn and DP-anti. When the expert assigned value couldn’t be calculated (the number of expert labs was lower than three), then the consensus value based on the combined results of participants and expert laboratories was used as assigned value. This approach was used only for α-HBCD and γ-HBCD. In the case of TBBPA, DBDPE and 2,4,6-TBP no assigned value could be determined due to a limited number of obtained results both from experts and participants.
Laboratory results were rated using Z-scores in accordance with ISO 13528 and ISO 17043. A fixed fit-for-purpose relative target standard deviation (FFP-RSDR) of 25% was applied for proficiency assessment. As mentioned above, in the case of TBBPA, DBDPE and 2,4,6-TBP no assessment of laboratories performance was done.